Table 3.
History of physical and psychiatric conditions
Current use | ||||
---|---|---|---|---|
Abstinent (n=63) | Low use (n=24) | Heavy use (n=24) | Total (N=111) | |
Physical comorbidities (%) | ||||
Any physical comorbidity | 44.4 | 62.5 | 54.2 | 50.5 |
Epilepsy or seizure disorder | 6.6 | 4.2 | 0.0 | 4.6 |
Liver disease | 4.9 | 12.5 | 0.0 | 5.6 |
Kidney disease | 1.6 | 0.0 | 0.0 | 0.9 |
Immune disorders | 1.6 | 0.0 | 4.4 | 1.9 |
Heart/cardiovascular conditions | 1.6 | 0.0 | 0.0 | 0.9 |
Asthma | 11.5 | 16.7 | 21.7 | 14.8 |
Other respiratory problems | 8.2 | 12.5 | 8.7 | 9.3 |
Diabetes | 3.3 | 0.0 | 4.4 | 2.8 |
Gastrointestinal disorders | 4.8 | 8.3 | 4.4 | 5.5 |
Chronic pain conditions | 11.5 | 20.8 | 26.1 | 16.7 |
Sexual Dysfunction | 1.6 | 0.0 | 8.7 | 2.8 |
Sexually transmitted diseases | 16.4 | 17.4 | 17.4 | 16.8 |
Sleep disorder | 21.0 | 26.1 | 21.7 | 22.2 |
Psychiatric comorbidities (%) | ||||
Any psychiatric comorbidity | 55.6 | 54.2 | 50.0 | 54.1 |
Schizophrenia | 6.6 | 0.0 | 0.0 | 3.7 |
Major depressive disorder | 22.6 | 26.1 | 21.7 | 23.2 |
Bipolar disorder | 18.0 | 30.4 | 13.0 | 19.6 |
Anxiety/PTSD/Panic disorder | 41.9 | 30.4 | 39.1 | 38.9 |
ADHD | 16.1 | 18.2 | 30.4 | 19.6 |
Group comparison based on Chi-square test
P<0.05,
P<0.01